Revenue (TTM) Chart

View Revenue (TTM) for ACU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 211.60M
March 31, 2026 202.88M
December 31, 2025 196.54M
September 30, 2025 194.96M
June 30, 2025 194.06M
March 31, 2025 195.49M
December 31, 2024 194.49M
September 30, 2024 190.49M
June 30, 2024 192.71M
March 31, 2024 190.62M
December 31, 2023 191.50M
September 30, 2023 193.66M
June 30, 2023 193.02M
March 31, 2023 196.46M
December 31, 2022 193.95M
September 30, 2022 195.64M
June 30, 2022 193.82M
March 31, 2022 181.90M
December 31, 2021 182.09M
September 30, 2021 177.17M
June 30, 2021 172.56M
March 31, 2021 171.75M
December 31, 2020 164.00M
September 30, 2020 157.01M
June 30, 2020 150.68M
Date Value
March 31, 2020 146.86M
December 31, 2019 142.46M
September 30, 2019 139.72M
June 30, 2019 137.45M
March 31, 2019 136.98M
December 31, 2018 137.32M
September 30, 2018 136.36M
June 30, 2018 135.42M
March 31, 2018 134.51M
December 31, 2017 130.55M
September 30, 2017 126.76M
June 30, 2017 124.88M
March 31, 2017 127.03M
December 31, 2016 124.57M
September 30, 2016 121.32M
June 30, 2016 119.31M
March 31, 2016 112.26M
December 31, 2015 109.81M
September 30, 2015 111.36M
June 30, 2015 111.47M
March 31, 2015 110.91M
December 31, 2014 107.22M
September 30, 2014 103.93M
June 30, 2014 96.06M
March 31, 2014 91.08M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Cencora, Inc. 332.77B
Abbott Laboratories 46.58B
Align Technology, Inc. 4.140B
AngioDynamics, Inc. 320.17M
Accuray, Inc. 401.95M